Supramolecular filamentous assemblies for protein purification

US11745165B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11745165-B2
Application numberUS-201816639763-A
CountryUS
Kind codeB2
Filing dateAug 17, 2018
Priority dateAug 18, 2017
Publication dateSep 5, 2023
Grant dateSep 5, 2023

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention provide novel immunofiber compositions for protein or peptide purification and simple and cost-efficient methods and systems using these compositions. In some embodiments, the immunofibers comprise a customized Z-33 peptide derived from Staphylococcus aureus Protein A which is used to construct immuno-amphiphile molecules that assemble into immunofibers in aqueous solution with bioactive epitopes on the surface and have peptide or protein binding ability.

First claim

Opening claim text (preview).

The invention claimed is: 1. An immunofiber composition comprising one or more immuno-amphiphiles, wherein said immuno-amphiphiles comprise an antibody binding peptide conjugated to a hydrocarbon chain; and wherein the antibody binding peptide comprises a hydrophilic amino acid sequence of the Z33 peptide of Protein A of Staphylococcus aureus or an antibody-binding fragment of Z33. 2. The immunofiber composition of claim 1 , wherein the immuno-amphiphile has an α-helical conformation when in an aqueous solution at physiological pH. 3. The immunofiber composition of claim 1 , wherein the antibody binding peptide comprises the amino acid sequence FNMQQQRRFYEALHDPNLNEEQRNAKIKSIRDD (SEQ ID NO: 1) or an antibody-binding fragment of SEQ ID NO: 1. 4. The immunofiber composition of claim 1 , wherein the antibody binding peptide has a hydrophilic amino acid sequence selected from the group consisting of SEQ ID NOS: 1-7. 5. The immunofiber composition of claim 1 , wherein the hydrocarbon chain is between 8 and 22 carbons in length and is either linear or branched. 6. The immunofiber composition of claim 5 , wherein the hydrocarbon chain is linear. 7. The immunofiber composition of claim 6 , wherein the hydrocarbon chain is between 8 and 12 carbons in length. 8. An immunofiber composition comprising an immunofiber binding molecule, wherein: said immunofiber binding molecule comprises an antibody binding peptide conjugated at its N-terminus to a spacer peptide and said spacer peptide is conjugated at its N-terminus to a hydrocarbon chain; said antibody binding peptide has a hydrophilic amino acid sequence of the Z33 peptide of Protein A of Staphylococcus aureus , an antibody-binding fragment of Z33, or an antibody-binding derivative of Z33; and said spacer peptide comprises the generic amino acid sequence of XXYYZZ, wherein XX is two amino acids having a small hydrophobic side chain and can be the same or different amino acid, YY is two amino acids having a positively charged side chain and can be the same or different amino acid, and ZZ is two amino acids having a small neutral side chain and can be the same or different amino acid. 9. The immunofiber composition of claim 8 , wherein the antibody binding peptide has the amino acid sequence FNMQQQRRFYEALHDPNLNEEQRNAKIKSIRDD (SEQ ID NO: 1), an antibody-binding fragment of SEQ ID NO: 1, or an antibody-binding derivative of SEQ ID NO: 1. 10. The immunofiber composition of claim 8 , wherein the antibody binding peptide has a hydrophilic amino acid sequence selected from the group consisting of SEQ ID NOS: 1-7. 11. The immunofiber composition of claim 8 , wherein the hydrocarbon chain is 8 carbons in length. 12. The immunofiber composition of claim 8 , wherein the amino acids having a small hydrophobic side chain are selected from the group consisting of: Ala, Val, Ile, and Leu. 13. The immunofiber composition of claim 8 , wherein the amino acids with a positively charged side chain are selected from the group consisting of: Arg, His and Lys. 14. The immunofiber composition of claim 8 , wherein the amino acids with a small neutral side chain are selected from the group consisting of: Gly and Pro. 15. A method for purifying antibodies or Fc containing peptides or proteins, the method comprising: a) dissolving immuno-amphiphiles in an aqueous solution having a physiological pH to provide an immuno-amphiphile solution; and aging said immuno-amphiphile solution overnight to provide an immunofiber solution comprising immunofibers, wherein said immuno-amphiphiles comprise an antibody binding peptide conjugated to a hydrocarbon chain; b) mixing a sample containing antibodies or Fc containing peptides or proteins with the immunofiber solution, and allowing the immunofibers to bind the Fc portion of the antibodies or Fc containing peptides or proteins and form an immunofiber-antibody complex or immunofiber-Fc containing peptide or protein complex in solution; c) separating the immunofiber-antibody complex or immunofiber-Fc containing peptide or protein complex from the solution by adding salt and centrifugation; d) dissociating the immunofibers from the antibodies or Fc containing peptides or proteins and collecting the unbound antibodies or Fc containing peptides or proteins. 16. The method of claim 15 , further comprising: e) separating the immunofibers from the antibodies or Fc containing peptides or proteins by lowering the pH to elution condition and filtration, microfiltration, or ultrafiltration. 17. The method of claim 15 , wherein the immunoglobulins or Fc containing peptides or proteins are further purified using polishing steps. 18. The method of claim 16 , wherein the immunoglobulins or Fc containing peptides or proteins are further purified using polishing steps.

Assignees

Inventors

Classifications

  • B01J20/24Primary

    Naturally occurring macromolecular compounds, e.g. humic acids or their derivatives · CPC title

  • of the antigen-antibody type, e.g. protein A, G or L chromatography · CPC title

  • Fibres or filaments (fibres or filaments in the form of membranes B01J20/28038; B01J20/28007 takes precedence) · CPC title

  • of sorbents or filter aids comprising organic materials · CPC title

  • in the liquid phase · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11745165B2 cover?
The present invention provide novel immunofiber compositions for protein or peptide purification and simple and cost-efficient methods and systems using these compositions. In some embodiments, the immunofibers comprise a customized Z-33 peptide derived from Staphylococcus aureus Protein A which is used to construct immuno-amphiphile molecules that assemble into immunofibers in aqueous solution…
Who is the assignee on this patent?
Univ Johns Hopkins, Bristol Myers Squibb Co
What technology area does this patent fall under?
Primary CPC classification B01J20/24. Mapped technology areas include Operations & Transport.
When was this patent published?
Publication date Tue Sep 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).